Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBC
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple-negative Breast Cancer
Interventions: DRUG: Albumin-Bound Paclitaxel|DRUG: Apatinib Mesylate|DRUG: Bevacizumab
Sponsor: First Affiliated Hospital Bengbu Medical College